Search for:
Category

Product Regulation and Liability

Category

On 1 August 2022, Swiss National Day, Switzerland’s revised Narcotics Act entered into force. The revision aims at facilitating medical treatments and improving research and development of cannabis. Prior to the revised law, patients and physicians had to apply for special authorization from the Federal Office of Public Health if they wanted to access cannabis for medical purposes. The amendment will allow numerous patients safe and timely access to cannabis medicines as part of their treatment regime. This signifies a further step in modernizing Switzerland’s legislation on cannabis.

The guide provides key legal information on the regulatory environment for digital health, potential legal issues, and other hot topics at the intersection of healthcare, data and technology.
To learn more about the latest trends and developments in digital healthcare in the Philippines, access the Philippine chapter of Chambers and Partners Digital Healthcare Global Guide 2022, exclusively authored by Quisumbing Torres.

The metaverse concept is going mainstream and is creating opportunities for companies to scale and diversify their businesses. In this episode of TMT Talk, Teresa Michaud, Ashlin Perumall, and Francis Donnat discuss what made metaverses into one of the biggest trending tech topics and what relevant legal aspects should businesses be aware of as they continue to evolve and become accessible to an audience beyond the gaming industry.

With a growing trend toward taking more ESG measures, some companies are at risk of lawsuits from consumers involving plastic packaging. In light of these trends, corporate boards should take steps to reduce the risk of ESG litigation in connection with their companies’ plastic recyclability labeling and use of plastics within their supply chains.

Baker McKenzie’s Sanctions Blog published the alert titled Ukraine: The law on cancelling marketing authorizations due to ties with Russian/Belarusian pharmaceutical manufacturing became applicable on 24 August 2022. Read the article via the link here. Please also visit our Sanctions Blog for the most recent updates.

EUR 4.30 instead of EUR 9.52 per gram: The reimbursable base price for medical cannabis cultivated in Germany has been almost cut in half whereas the base price for imported cannabis flowers remains unaffected. According to an arbitration ruling of 17 June 2022, a base price of EUR 4.30 (plus surcharges of 90% or 100%) per gram is reimbursable for cannabis flowers cultivated in Germany. Prior to the ruling, statutory health insurance funds reimbursed a base price of EUR 9.52 per gram plus varying surcharges for all cannabis flowers. This also applied to cannabis flowers cultivated in Germany and sold to pharmacies for a fixed price of only EUR 4.30 per gram.

The Annual Compliance Conference begins next week and attracts over 6,000 in-house senior legal and compliance professionals from across the world. This leading compliance conference will be held across five weeks from 6 September – 6 October 2022. We will be virtually delivering our cutting-edge insights and guidance on key global compliance, investigations and ethics issues. Our global experts will provide practical insights and analysis on significant developments:
• anti-bribery
• corruption and economic crime
• customs and FTAs
• ESG, supply chain and product compliance
• antitrust and competition
• export controls, sanctions and foreign investment

Click here to view the full agenda and register your interest in joining us virtually at this must attend global compliance conference for senior in-house legal and compliance professionals.